Abstract
Aspirin as a class I guideline recommended medical treatment for acute coronary syndrome has been established for decades [1]. As early intake of aspirin is crucial, self-administration of aspirin in acute chest pain might be beneficial when weighing up the potential harm including a slightly elevated bleeding risk in patients with chest pain of another origin than myocardial infarction against the benefit in patients with coronary ischemia.
| Original language | English |
|---|---|
| Pages (from-to) | 291-296 |
| Number of pages | 6 |
| Journal | Wiener Klinische Wochenschrift. The Central European Journal of Medicine |
| Volume | 137 |
| Issue number | 9 |
| Early online date | 17 Dec 2024 |
| DOIs | |
| Publication status | Published - May 2025 |